A medical oncologist called the late-stage clinical trial results “remarkable,” though Sasse said the drug means his body ...
Two genetic variants may help explain differences in side effects and weight loss in patients taking GLP-1 drugs.
Researchers have identified a surprising metabolic effect of a widely used diabetes drug in men undergoing prostate cancer treatment.
Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, ...
The review said a certain class of drugs had little clinical benefit, but many Alzheimer’s experts criticized the analysis, ...
Mild side effects of Tymlos include dizziness, headache, and fatigue. Mild side effects are usually temporary, lasting a few days to weeks. While rare, Tymlos may cause serious side effects such as ...
Reproductive symptoms, temperature-related complaints, and psychiatric symptoms are among the side effects of GLP-1s reported ...
It's the latest in a long-running dispute over the drugs, which some view as groundbreaking, while others say they leave much ...
President Trump signed an order to speed federal review of psychedelic drugs for mental health treatment, including plans to fast-track research and approvals.
'Indiscriminate use can lead to complications.' IMAGE: Pens for the diabetes drug Ozempic sit on a production line to be ...
Revolution Medicines' drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial, the company said.
Top drugmakers have spent more than a decade investigating and advancing anti-amyloid Alzheimer's medicines in clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results